C19H19ClF3N3O2
413.8 g/mol
APIWarning
Lasmiditan hydrochloride
CAS613677-28-4
Category
API
Compound Class
Amine
Primary Use
Pharmaceutical Raw Material
Lasmiditan hydrochloride is a salt form of lasmiditan, a pharmaceutical compound primarily used in the manufacture of medications for acute migraine treatment. It is an active pharmaceutical ingredient (API) supplied for pharmaceutical production and research.
Active pharmaceutical ingredient in migraine treatment medicationsPharmaceutical manufacturing intermediateResearch compound for neurological studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 613677-28-4
Related Compounds
StrongSame Parent
Lasmiditan
CAS439239-90-4
pharmaceutical raw material
StrongSame Parent
Lasmiditan succinate
CAS439239-92-6
pharmaceutical raw material
ReferenceSame Category
Rifapentine
CAS61379-65-5
pharmaceutical raw material
ReferenceSame Category
Triprolidine hydrochloride monohydrate
CAS6138-79-0
pharmaceutical raw material
ReferenceSame Category
(-)-oxedrine
CAS614-35-7
pharmaceutical raw material
ReferenceSame Category
Procainamide hydrochloride
CAS614-39-1
pharmaceutical raw material
Safety Reference
Warning
H302Harmful if swallowed
H318Causes serious eye damage
H336May cause drowsiness or dizziness
H361Suspected of damaging fertility or the unborn child
Identifiers
IUPAC Name
2,4,6-trifluoro-N-[6-(1-methylpiperidine-4-carbonyl)-2-pyridinyl]benzamide;hydrochloride
InChIKey
YBTPRLDGGGYWIP-UHFFFAOYSA-N
SMILES
CN1CCC(CC1)C(=O)C2=NC(=CC=C2)NC(=O)C3=C(C=C(C=C3F)F)F.Cl
Synonyms (8)
- COL-144 hydrochloride
- LY-573144 Hydrochloride
- Lasmiditan HCl
- Lasmiditan hydrochloride